Geneva, May 4 -- International Clinical Trials Registry received information related to the study (DRKS00040022) titled 'Artificial Intelligence RIsk Stratification for Skeletal-Related Events' on April 22.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: Prognosis
Primary Sponsor: Klinik und Poliklinik fur Urologie und Kinderurologie, Universitatsklinikum Bonn
Condition:
C61
Malignant neoplasm of prostate
Intervention:
Group 1: Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) patients routinely undergoing CT-based staging
Recruitment Status: Not Recruiting
Date of First Enrollment: 01/05/2026
Target Sample Size: 100
Countries of Recruitment:
Germany
To know more, ...